drugset / Trial / NCT00567814

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction

NCT00567814

Completed 45 enrolled Embera NeuroTherapeutics, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Subjects will be randomly assigned to receive either one of the two potential dose combinations of the study medications or placebo over 6 weeks. The study will include twice weekly visits to the research clinic for laboratory studies, safety assessments and urine drug screens. Subjects will also be questioned regarding drug craving and mood symptoms.

Timeline

Start
2007-12
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metyrapone Small molecule
Comparator oxazepam Small molecule

Indications